Community-acquired methicillin-resistant staphylococcus aureus: diagnosis and treatment update for plastic surgeons.
OBJECTIVE
: After studying this article, the participant should be able to: 1. Identify risk factors associated with community-acquired methicillin-resistant Staphylococcus aureus. 2. Recognize the clinical presentation of patients with community-acquired methicillin-resistant S. aureus. 3. Understand the treatment and indications for decolonization of patients who have community-acquired methicillin-resistant S. aureus infections.


CONCLUSIONS
: Community-acquired methicillin-resistant Staphylococcus aureus has evolved over the past 10 years as a new health threat seen by plastic surgeons and is an increasing cause of soft-tissue infections. This pathogen has several distinct virulence factors and unique antimicrobial susceptibilities that distinguish methicillin-resistant S. aureus from traditional hospital-acquired methicillin-resistant S. aureus. This article reviews the epidemiology, risk factors, clinical presentation, and treatment of community-acquired methicillin-resistant S. aureus.
Stacey
D Heath
DH
Madison, Wis. From the Divisions of Plastic Surgery and Infectious Disease, University of Wisconsin.
Fox
Barry C
BC
Poore
Samuel O
SO
Bentz
Michael L
ML
Gutowski
Karol A
KA
D000328:Adult; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D016106:Methicillin Resistance; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D013211:Staphylococcus aureus / Q000302:isolation & purification*; D013518:Surgery, Plastic